In this issue of Blood, Kim and colleagues demonstrate that the Fanconi anemia protein FANCP/SLX4 is multifunctional by identifying molecular domains that uniquely effect repair of DNA damage inflicted by either DNA cross-linkers or topoisomerase and PARP inhibitors.
CITATION STYLE
Hays, L. E. (2013, January 3). Multifunctionality of the FA pathway. Blood. American Society of Hematology. https://doi.org/10.1182/blood-2012-11-464636
Mendeley helps you to discover research relevant for your work.